A study frequently mentioned in our studies [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40] was a multicenter, randomized, double-blind, placebo-controlled study [257], which was performed to assess the efficacy, safety, and pharmacokinetics of BPC 157 in patients with mild to moderate ulcerative colitis
References Mischley LK, Conley, KE, Shankland EG et al
However, if ER stress remains unresolved, it can lead to apoptosis, making this pathway particularly relevant in the context of neurodegenerative diseases
Additionally, the potential of AS-IV to mitigate toxicity when co-administered with anticancer drugs is explored, highlighting its broader therapeutic applicability and role in optimizing polypharmacy strategies for improved patient outcomes (Figure 2)